Pressure injury treatment by intermittent electrical stimulation (PROTECT-2): protocol for a multicenter randomized clinical trial.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
10 May 2024
Historique:
received: 28 06 2023
accepted: 02 04 2024
medline: 11 5 2024
pubmed: 11 5 2024
entrez: 10 5 2024
Statut: epublish

Résumé

Pressure ulcers account for a substantial fraction of hospital-acquired pathology, with consequent morbidity and economic cost. Treatments are largely focused on preventing further injury, whereas interventions that facilitate healing remain limited. Intermittent electrical stimulation (IES) increases local blood flow and redistributes pressure from muscle-bone interfaces, thus potentially reducing ulcer progression and facilitating healing. The Pressure Injury Treatment by Intermittent Electrical Stimulation (PROTECT-2) trial will be a parallel-arm multicenter randomized trial to test the hypothesis that IES combined with routine care reduces sacral and ischial pressure injury over time compared to routine care alone. We plan to enroll 548 patients across various centers. Hospitalized patients with stage 1 or stage 2 sacral or ischial pressure injuries will be randomized to IES and routine care or routine care alone. Wound stage will be followed until death, discharge, or the development of an exclusion criteria for up to 3 months. The primary endpoint will be pressure injury score measured over time. Sacral and ischial pressure injuries present a burden to hospitalized patients with both clinical and economic consequences. The PROTECT-2 trial will evaluate whether IES is an effective intervention and thus reduces progression of stage 1 and stage 2 sacral and ischial pressure injuries. ClinicalTrials.gov NCT05085288 Registered October 20, 2021.

Sections du résumé

BACKGROUND BACKGROUND
Pressure ulcers account for a substantial fraction of hospital-acquired pathology, with consequent morbidity and economic cost. Treatments are largely focused on preventing further injury, whereas interventions that facilitate healing remain limited. Intermittent electrical stimulation (IES) increases local blood flow and redistributes pressure from muscle-bone interfaces, thus potentially reducing ulcer progression and facilitating healing.
METHODS METHODS
The Pressure Injury Treatment by Intermittent Electrical Stimulation (PROTECT-2) trial will be a parallel-arm multicenter randomized trial to test the hypothesis that IES combined with routine care reduces sacral and ischial pressure injury over time compared to routine care alone. We plan to enroll 548 patients across various centers. Hospitalized patients with stage 1 or stage 2 sacral or ischial pressure injuries will be randomized to IES and routine care or routine care alone. Wound stage will be followed until death, discharge, or the development of an exclusion criteria for up to 3 months. The primary endpoint will be pressure injury score measured over time.
DISCUSSION CONCLUSIONS
Sacral and ischial pressure injuries present a burden to hospitalized patients with both clinical and economic consequences. The PROTECT-2 trial will evaluate whether IES is an effective intervention and thus reduces progression of stage 1 and stage 2 sacral and ischial pressure injuries.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT05085288 Registered October 20, 2021.

Identifiants

pubmed: 38730383
doi: 10.1186/s13063-024-08085-x
pii: 10.1186/s13063-024-08085-x
doi:

Banques de données

ClinicalTrials.gov
['NCT05085288']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

313

Subventions

Organisme : Rehabtronics, INC
ID : RHTX2112CD

Informations de copyright

© 2024. The Author(s).

Références

Labeau SO, Afonso E, Benbenishty J, Blackwood B, Boulanger C, Brett SJ. Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study. Intensive Care Med. 2020;47(2):160–9. https://doi.org/10.1007/s00134-020-06234-9 .
doi: 10.1007/s00134-020-06234-9 pubmed: 33034686 pmcid: 7880913
Woodbury MG, Houghton PE. Prevalence of pressure ulcers in Canadian healthcare settings. Ostomy Wound Manage. 2004;50(10):22–4. 26, 28, 30, 32, 34, 36-28.
pubmed: 15509880
Zulkowski K, Langemo D, Posthauer ME. Coming to consensus on deep tissue injury. Adv Skin Wound Care. 2005;18(1):28–9. https://doi.org/10.1097/00129334-200501000-00013 .
doi: 10.1097/00129334-200501000-00013 pubmed: 15714033
Gefen A. How much time does it take to get a pressure ulcer? Integrated evidence from human, animal, and in vitro studies. Ostomy Wound Manage. 2008;54(10):26–8. 30-25.
pubmed: 18927481
Lima Serrano M, González Méndez MI, Carrasco Cebollero FM, Lima Rodríguez JS. Risk factors for pressure ulcer development in intensive care units: a systematic review. Med Intensiva. 2017;41(6):339–46. https://doi.org/10.1016/j.medin.2016.09.003 .
doi: 10.1016/j.medin.2016.09.003 pubmed: 27780589
Coyer F, Miles S, Gosley S, Fulbrook P, Sketcher-Baker K, Cook JL, et al. Pressure injury prevalence in intensive care versus non-intensive care patients: a state-wide comparison. Aust Crit Care. 2017;30:244–50.
doi: 10.1016/j.aucc.2016.12.003 pubmed: 28063724
Solis LR, Hallihan DP, Uwiera RR, Thompson RB, Pehowich ED, Mushahwar VK. Prevention of pressure-induced deep tissue injury using intermittent electrical stimulation. J Appl Physiol (1985). 2007;102(5):1992–2001. https://doi.org/10.1152/japplphysiol.01092.2006 .
doi: 10.1152/japplphysiol.01092.2006 pubmed: 17272408
Gyawali S, Solis L, Chong SL, Curtis C, Seres P, Kornelsen I, Mushahwar VK. Intermittent electrical stimulation redistributes pressure and promotes tissue oxygenation in loaded muscles of individuals with spinal cord injury. J Appl Physiol (1985). 2011;110(1):246–55. https://doi.org/10.1152/japplphysiol.00661.2010 .
doi: 10.1152/japplphysiol.00661.2010 pubmed: 20884840
Solis L, Gyawali S, Curtis CA, Chong S, Thompson R, Mushahwar V. Changes in superficial pressure and tissue oxygenation levels due to contractions elicited by intermittent electrical stimulation for the prevention of deep tissue injury. Freiburg: 13th International FES Society Conference; 2008.
Ahmetović A, Mushahwar VK, Sommer R, Schnepf D, Kawasaki L, Warwaruk-Rogers R, ... Chan KM. Safety and feasibility of intermittent electrical stimulation for the prevention of deep tissue injury. Adv Wound Care. 2015;4(3):192–201. https://doi.org/10.1089/wound.2014.0569 .
Kane A, Warwaruk-Rogers R, Ho C, Chan M, Stein R, Mushahwar VK, Dukelow SP. A feasibility study of intermittent electrical stimulation to prevent deep tissue injury in the intensive care unit. Adv Wound Care. 2017;6(4):115–24. https://doi.org/10.1089/wound.2016.0686 .
doi: 10.1089/wound.2016.0686
Chan A-W, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin J, Dickersin K, Hrobjartsson A, Schulz KF, Parulekar WR, Krleza-Jeric K, Laupacis A, Moher D. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.
doi: 10.1136/bmj.e7586 pubmed: 23303884 pmcid: 3541470
Zhang Z. Multiple imputation with multivariate imputation by chained equation (MICE) package. Ann Transl Med. 2016;4(2):30–30. https://doi.org/10.3978/j.issn.2305-5839.2015.12.63 .
doi: 10.3978/j.issn.2305-5839.2015.12.63 pubmed: 26889483 pmcid: 4731595
Gebski V, Byth K, Asher R, et al. Recurrent time-to-event models with ordinal outcomes. Pharm Stat. 2021;20(1):77–92. https://doi.org/10.1002/pst.2057 .
doi: 10.1002/pst.2057 pubmed: 33006268
Rutterford C, Copas A, Eldridge S. Methods for sample size determination in cluster randomized trials. Int J Epidemiol. 2015;44(3):1051–67. https://doi.org/10.1093/ije/dyv113 .
doi: 10.1093/ije/dyv113 pubmed: 26174515 pmcid: 4521133
Ahtiala MH, Kivimäki R, Laitio R, Soppi ET. The Association Between Pressure Ulcer/Injury Development and Short-term Mortality in Critically Ill Patients: A Retrospective Cohort Study. Wound Manag Prev. 2020;66(2):14–21. https://doi.org/10.25270/wmp.2020.2.1421 .

Auteurs

Chase Donaldson (C)

Department of Intensive Care and Resuscitation, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA. donaldc@ccf.org.

Marcelo Gama de Abreu (MG)

Department of Intensive Care and Resuscitation, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.

Edward J Mascha (EJ)

Department of Quantitative Health Sciences and Outcomes Research, Lerner Research Institute; Outcomes Research Consortium, Department of Anesthesiology, Hospital Based Care Institute, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.

James Rowbottom (J)

Department of Intensive Care and Resuscitation, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.

Eric Harvester (E)

Department of Intensive Care and Resuscitation, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.

Ashish Khanna (A)

Department of Anesthesiology, Section On Critical Care Medicine, Wake Forest University School of Medicine, Atrium Health Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC, 27157, USA.

Tanmay Sura (T)

Department of Anesthesiology, 100 Medical Center Blvd, Winston-Salem, NC, 27157, USA.

Daniel I Sessler (DI)

Outcomes Research Consortium, Department of Anesthesiology, Hospital Based Care Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.

Fabio Rodriguez Patarroyo (FR)

Outcomes Research Consortium, Department of Anesthesiology, Hospital Based Care Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.

Alper Gulluoglu (A)

Outcomes Research Consortium, Department of Anesthesiology, Hospital Based Care Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.

Paul Zajic (P)

Department of Anaesthesiology and Intensive Care Medicine, Medical University of Graz, Auenbruggerpl, 5, Graz, 8036, Austria.

Utkarsh Chauhan (U)

University of Alberta Medical School, 1-002 Katz Group Centre for Pharmacy and Health Research, Edmonton, AB, T6G 2E1, Canada.

Hani Essber (H)

Department of Anaesthesiology and Intensive Care Medicine, Medical University of Graz, Auenbruggerpl, 5, Graz, 8036, Austria.

Andrea Kurz (A)

Departments of General Anesthesiology and Outcomes Research Consortium, Department of Anesthesiology, Hospital Based Care Institute, Cleveland Clinic , 9500 Euclid Avenue, Cleveland, OH, 44195, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH